Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6701042

CC(C)CNc1ccc(F)cc1.N

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
ALOX12 P18054 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK14 Q16539 2/20 0.39
ESR1 P03372 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1565673 0.98 ALDH1A1 (0.42) ALDH1A1ALOX12SMN1; SMN2KDM4EGAA
SCHEMBL146034 0.86 IDO1 (0.45) ALDH1A1SMN1; SMN2GAAALOX15HSD17B10
SCHEMBL8611549 0.81 NPC1 (0.46) ALDH1A1SMN1; SMN2KDM4EGAACA1
SCHEMBL22414272 0.80 MAPT (0.37) ALDH1A1SMN1; SMN2CA1CA2CA12
Ammonia Solution, Strong SCHEMBL6698868 0.80 MAPT (0.56) ALDH1A1SMN1; SMN2KDM4EGAAHPGD
SCHEMBL23504460 0.79 CA1 (0.39) SMN1; SMN2KDM4ECA1CA2CA12
SCHEMBL26000374 0.78 MEN1 (0.47) ALOX12SMN1; SMN2KDM4EGAAHPGD
SCHEMBL25095026 0.77 TSHR (0.40) ALDH1A1SMN1; SMN2HPGDALOX15HSD17B10
SCHEMBL7794063 0.77 MAPT (0.58) ALDH1A1SMN1; SMN2KDM4EGAAHPGD
Ammonia Solution, Strong SCHEMBL6702357 0.77 MAPT (0.50) ALDH1A1ALOX12SMN1; SMN2ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040180925-A1 Dipeptidylpeptidase-IV inhibitor KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-09-16 US disclosed
EP-1354882-A1 DIPEPTIDYL PEPTIDASE IV INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040180925-A1 Dipeptidylpeptidase-IV inhibitor DPP4, DPP3, DPP9 ALDH1A1 925/4885ALOX12 3909/4885SMN1; SMN2 3810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.